Cronos Group Inc. (CRON)

Market Cap	742.12M
Revenue (ttm)	111.23M
Net Income (ttm)	-47.44M
Shares Out	382.29M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,898,349
Open	1.860
Previous Close	1.870
Day's Range	1.860 - 1.970
52-Week Range	1.860 - 3.140
Beta	1.01
Analysts	Hold
Price Target	3.00 (+53.85%)
Earnings Date	Nov 12, 2024

About CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2012
• Employees: 356
• Stock Exchange: NASDAQ
• Ticker Symbol: CRON
• Website: https://www.thecronosgroup.com

Financial Performance

In 2023, Cronos Group's revenue was $87.24 million, an increase of 0.57% compared to the previous year's $86.75 million. Losses were -$73.96 million, -56.17% less than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for CRON stock is "Hold." The 12-month stock price forecast is $3.0, which is an increase of 53.85% from the latest price.

Price Target

$3.0

(53.85% upside)

Analyst Consensus: Hold